Chemed Stock Price, News & Analysis (NYSE:CHE)

$263.97 2.36 (0.90 %)
(As of 01/18/2018 02:12 PM ET)
Previous Close$261.61
Today's Range$260.53 - $264.48
52-Week Range$163.50 - $266.31
Volume85,800 shs
Average Volume94,736 shs
Market Capitalization$4.21 billion
P/E Ratio58.79
Dividend Yield0.43%
Beta1.16

About Chemed (NYSE:CHE)

Chemed logoChemed Corporation purchases, operates and divests subsidiaries engaged in various business activities. The Company operates through two segments: the VITAS segment (VITAS) and the Roto-Rooter segment (Roto-Rooter). The Company's VITAS provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers. VITAS is the provider of hospice services in an industry dominated primarily by small, non-profit, community-based hospices. VITAS provides hospice care to Medicare beneficiaries participating in these managed care programs. A portion of its VITAS business is operated in the state of Florida. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration and other related services to both residential and commercial customers.

Receive CHE News and Ratings via Email

Sign-up to receive the latest news and ratings for CHE and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Healthcare Facilities & Services
Sub-IndustryHealth Care Services
SectorHealthcare
SymbolNYSE:CHE
CUSIP16359R10
Phone+1-513-7626690

Debt

Debt-to-Equity Ratio0.15%
Current Ratio0.50%
Quick Ratio0.48%

Price-To-Earnings

Trailing P/E Ratio58.7906458797327
Forward P/E Ratio55.81
P/E Growth2.94

Sales & Book Value

Annual Sales$1.58 billion
Price / Sales2.67
Cash Flow$9.53 per share
Price / Cash27.70
Book Value$32.30 per share
Price / Book8.17

Profitability

Trailing EPS$4.49
Net Income$108.74 million
Net Margins4.62%
Return on Equity27.69%
Return on Assets15.16%

Miscellaneous

Employees14,613
Outstanding Shares15,970,000

Chemed (NYSE:CHE) Frequently Asked Questions

What is Chemed's stock symbol?

Chemed trades on the New York Stock Exchange (NYSE) under the ticker symbol "CHE."

How often does Chemed pay dividends? What is the dividend yield for Chemed?

Chemed declared a quarterly dividend on Friday, November 3rd. Investors of record on Monday, November 13th will be given a dividend of $0.28 per share on Monday, December 4th. This represents a $1.12 annualized dividend and a yield of 0.42%. The ex-dividend date is Friday, November 10th. View Chemed's Dividend History.

How will Chemed's stock buyback program work?

Chemed announced that its board has initiated a share buyback program on Monday, April 10th 2017, which authorizes the company to repurchase $100,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization authorizes the company to buy up to 3.3% of its shares through open market purchases. Shares repurchase programs are often a sign that the company's board believes its stock is undervalued.

How were Chemed's earnings last quarter?

Chemed Co. (NYSE:CHE) issued its earnings results on Thursday, October, 26th. The company reported $2.15 EPS for the quarter, topping the consensus estimate of $2.00 by $0.15. The company had revenue of $417.40 million for the quarter, compared to analyst estimates of $414.34 million. Chemed had a return on equity of 27.69% and a net margin of 4.62%. Chemed's revenue was up 6.3% on a year-over-year basis. During the same period last year, the business earned $1.73 earnings per share. View Chemed's Earnings History.

When will Chemed make its next earnings announcement?

Chemed is scheduled to release their next quarterly earnings announcement on Wednesday, February, 14th 2018. View Earnings Estimates for Chemed.

What guidance has Chemed issued on next quarter's earnings?

Chemed updated its FY17 earnings guidance on Thursday, October, 26th. The company provided earnings per share (EPS) guidance of $8.35-$8.40 for the period, compared to the Thomson Reuters consensus estimate of $8.19.

Where is Chemed's stock going? Where will Chemed's stock price be in 2018?

3 equities research analysts have issued 12 month price objectives for Chemed's stock. Their forecasts range from $225.00 to $232.00. On average, they expect Chemed's share price to reach $228.50 in the next year. View Analyst Ratings for Chemed.

Who are some of Chemed's key competitors?

Who are Chemed's key executives?

Chemed's management team includes the folowing people:

  • George J. Walsh III, Independent Chairman of the Board (Age 71)
  • Kevin J. McNamara, President, Chief Executive Officer, Director (Age 63)
  • David Patrick Williams, Chief Financial Officer, Executive Vice President (Age 56)
  • Spencer S. Lee, Executive Vice President (Age 61)
  • Nicholas Michael Westfall, Executive Vice President (Age 38)
  • Michael D. Witzeman, Principal Accounting Officer, Controller (Age 46)
  • Thomas Charles Hutton, Director (Age 66)
  • Joel F. Gemunder, Independent Director (Age 77)
  • Patrick P. Grace, Independent Director (Age 61)
  • Walter L. Krebs, Independent Director (Age 84)

Who owns Chemed stock?

Chemed's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Acadian Asset Management LLC (3.56%), Schwab Charles Investment Management Inc. (0.68%), Louisiana State Employees Retirement System (0.04%), Bank of Montreal Can (0.03%), Hutchens Investment Management Inc (0.01%) and Charter Trust Co. (0.01%). Company insiders that own Chemed stock include Arthur V Tucker Jr, David Patrick Williams, Donald E Saunders, George J Walsh III, Kevin J Mcnamara, Michael D Witzeman, Naomi C Dallob, Nicholas Michael Westfall, Patrick P Grace and Spencer S Lee. View Institutional Ownership Trends for Chemed.

Who sold Chemed stock? Who is selling Chemed stock?

Chemed's stock was sold by a variety of institutional investors in the last quarter, including Acadian Asset Management LLC and Bank of Montreal Can. Company insiders that have sold Chemed company stock in the last year include Arthur V Tucker Jr, David Patrick Williams, Donald E Saunders, Kevin J Mcnamara, Michael D Witzeman, Naomi C Dallob, Nicholas Michael Westfall, Patrick P Grace and Spencer S Lee. View Insider Buying and Selling for Chemed.

Who bought Chemed stock? Who is buying Chemed stock?

Chemed's stock was bought by a variety of institutional investors in the last quarter, including Schwab Charles Investment Management Inc., Hutchens Investment Management Inc, Charter Trust Co. and Louisiana State Employees Retirement System. Company insiders that have bought Chemed stock in the last two years include Donald E Saunders and George J Walsh III. View Insider Buying and Selling for Chemed.

How do I buy Chemed stock?

Shares of Chemed can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Chemed's stock price today?

One share of Chemed stock can currently be purchased for approximately $263.97.

How big of a company is Chemed?

Chemed has a market capitalization of $4.21 billion and generates $1.58 billion in revenue each year. The company earns $108.74 million in net income (profit) each year or $4.49 on an earnings per share basis. Chemed employs 14,613 workers across the globe.

How can I contact Chemed?

Chemed's mailing address is 255 E 5th St Ste 2600, CINCINNATI, OH 45202-4138, United States. The company can be reached via phone at +1-513-7626690.


MarketBeat Community Rating for Chemed (CHE)

Community Ranking:  2.0 out of 5 (star star)
Outperform Votes:  122 (Vote Outperform)
Underperform Votes:  178 (Vote Underperform)
Total Votes:  300
MarketBeat's community ratings are surveys of what our community members think about Chemed and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Chemed (NYSE:CHE) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldBuyHold
Consensus Rating Score: 2.332.332.502.33
Ratings Breakdown: 0 Sell Rating(s)
2 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $228.50$228.50$214.50$181.50
Price Target Upside: 2.63% upside2.63% upside5.41% upside11.88% downside

Chemed (NYSE:CHE) Consensus Price Target History

Price Target History for Chemed (NYSE:CHE)

Chemed (NYSE:CHE) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
10/31/2017Royal Bank of CanadaBoost Price TargetPositive -> Sector Perform$232.00N/AView Rating Details
10/27/2017OppenheimerBoost Price TargetOutperform$220.00 -> $225.00N/AView Rating Details
10/27/2017KeyCorpReiterated RatingHoldN/AView Rating Details
8/13/2017National Bank FinancialUpgradeSector Perform Market Weight -> Outperform Market WeightN/AView Rating Details
9/4/2016JMP SecuritiesReiterated RatingHoldN/AView Rating Details
(Data available from 1/18/2016 forward)

Earnings

Chemed (NYSE:CHE) Earnings History and Estimates Chart

Earnings by Quarter for Chemed (NYSE:CHE)

Chemed (NYSE CHE) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/14/2018$2.27N/AView Earnings Details
10/26/2017Q3 2017$2.00$2.15$414.34 million$417.40 millionViewN/AView Earnings Details
7/25/2017Q2 2017$1.89$2.15$407.56 million$415.06 millionViewN/AView Earnings Details
4/26/2017Q1 2017$1.78$1.82$399.75 million$405.90 millionViewN/AView Earnings Details
2/15/2017Q416$2.10$2.10$409.89 million$403.00 millionViewListenView Earnings Details
10/26/2016Q316$1.82$1.73$270.44 million$392.61 millionViewListenView Earnings Details
7/25/2016Q216$1.72$1.80$393.50 million$290.00 millionViewListenView Earnings Details
4/28/2016Q116$1.58$1.62$391.68 million$390.40 millionViewListenView Earnings Details
2/17/2016Q415$1.81$1.97$390.22 million$398.60 millionViewListenView Earnings Details
10/22/2015Q315$1.61$1.78$375.95 million$386.23 millionViewListenView Earnings Details
7/23/2015Q215$1.59$1.71$375.01 million$382.00 millionViewListenView Earnings Details
4/28/2015Q115$1.35$1.54$370.76 million$377.00 millionViewListenView Earnings Details
2/17/2015Q414$1.65$1.80$372.54 million$379.00 millionViewListenView Earnings Details
10/30/2014Q314$1.34$1.40$360.00 million$358.40 millionViewListenView Earnings Details
8/7/2014$0.32$0.30$319.70 million$310.06 millionViewN/AView Earnings Details
7/23/2014Q214$1.31$1.50$363.73 million$360.18 millionViewListenView Earnings Details
4/29/2014Q114$1.23$1.32$256.77 million$358.30 millionViewListenView Earnings Details
2/17/2014Q4 2013$1.40ViewN/AView Earnings Details
10/29/2013Q313$1.34$1.36$355.40 million$340.90 millionViewListenView Earnings Details
7/18/2013Q2 2013$1.33$1.44$368.06 million$357.00 millionViewListenView Earnings Details
4/18/2013Q1 2013$1.29$1.38$365.08 million$367.00 millionViewListenView Earnings Details
2/18/2013Q4 2012$1.15$1.57$355.31 million$369.00 millionViewListenView Earnings Details
10/29/2012Q312$1.35$1.28$360.50 million$354.00 millionViewN/AView Earnings Details
7/25/2012$1.26$1.26ViewN/AView Earnings Details
4/19/2012$1.25$1.21ViewN/AView Earnings Details
2/14/2012$1.48$1.45ViewN/AView Earnings Details
10/25/2011$1.15$1.20ViewN/AView Earnings Details
7/26/2011Q2 2011$1.07$1.01ViewN/AView Earnings Details
4/26/2011$0.98$1.07ViewN/AView Earnings Details
2/15/2011$1.05$0.98ViewN/AView Earnings Details
10/25/2010Q3 2010$0.93$0.97ViewN/AView Earnings Details
7/28/2010Q2 2010$0.91$0.92ViewN/AView Earnings Details
4/20/2010Q1 2010$0.91$0.89ViewN/AView Earnings Details
2/15/2010Q4 2009$0.94$1.00ViewN/AView Earnings Details
10/27/2009Q3 2009$0.89$0.90ViewN/AView Earnings Details
7/30/2009Q2 2009$0.83$0.90ViewN/AView Earnings Details
4/22/2009Q1 2009$0.84$0.94ViewN/AView Earnings Details
2/16/2009Q4 2008$0.92$0.93ViewN/AView Earnings Details
10/21/2008Q3 2008$0.76$0.79ViewN/AView Earnings Details
7/28/2008Q2 2008$0.72$0.73ViewN/AView Earnings Details
4/24/2008Q1 2008$0.85$0.69ViewN/AView Earnings Details
2/21/2008Q4 2007$0.87$0.92ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Chemed (NYSE:CHE) Earnings Estimates

2018 EPS Consensus Estimate: $8.61
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20181$1.95$1.95$1.95
Q2 20181$2.09$2.09$2.09
Q3 20181$2.14$2.14$2.14
Q4 20181$2.43$2.43$2.43
(Earnings estimates data provided by Zacks Investment Research)

Dividends

Chemed (NYSE:CHE) Dividend Information

Most Recent Dividend:12/4/2017
Annual Dividend:$1.12
Dividend Yield:0.42%
Dividend Growth:8.70% (3 Year Average)
Payout Ratio:24.94% (Trailing 12 Months of Earnings)
23.68% (Based on This Year's Estimates)
12.57% (Based on Next Year's Estimates)
Track Record:9 Years of Consecutive Dividend Growth
Frequency:Quarterly Dividend
Dividend Payments by Quarter for Chemed (NYSE:CHE)

Chemed (NYSE:CHE) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
11/3/2017Quarterly$0.280.48%11/10/201711/13/201712/4/2017
9/22/2017Monthly$0.109/28/20179/29/201710/31/2017
8/23/2017Monthly$0.108/29/20178/31/20179/29/2017
8/4/2017quarterly$0.280.57%8/10/20178/14/20179/1/2017
7/21/2017Monthly$0.107/27/20177/31/20178/31/2017
6/22/2017Monthly$0.106/28/20176/30/20177/31/2017
5/15/2017Quarterly$0.260.51%5/23/20175/25/20176/14/2017
2/17/2017quarterly$0.260.59%2/23/20172/27/20173/20/2017
11/4/2016quarterly$0.260.76%11/9/201611/14/201612/5/2016
8/5/2016quarterly$0.260.72%8/11/20168/15/20169/2/2016
5/16/2016quarterly$0.240.76%5/24/20165/26/20166/15/2016
2/19/2016quarterly$0.240.75%2/25/20162/29/20163/21/2016
11/6/2015quarterly$0.240.63%11/12/201511/16/201512/7/2015
8/7/2015quarterly$0.240.63%8/13/20158/17/20159/4/2015
5/18/2015quarterly$0.220.71%5/26/20155/28/20156/17/2015
2/20/2015quarterly$0.220.77%2/26/20153/2/20153/23/2015
11/7/2014quarterly$0.220.81%11/13/201411/17/201412/8/2014
8/11/2014quarterly$0.220.88%8/14/20148/18/20149/13/2014
8/8/2014quarterly$0.228/14/20148/18/20149/3/2014
5/19/2014quarterly$0.200.91%5/27/20145/29/20146/18/2014
2/21/2014quarterly$0.200.94%2/27/20143/3/20143/24/2014
11/8/2013quarterly$0.201.13%11/14/201311/18/201312/9/2013
8/2/2013quarterly$0.201.1%8/8/20138/12/20139/3/2013
5/20/2013quarterly$0.181.05%5/28/20135/30/20136/19/2013
2/20/2013quarterly$0.180.92%2/28/20133/4/20133/22/2013
(Data available from 1/1/2013 forward)

Insider Trades

Chemed (NYSE CHE) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 4.90%
Institutional Ownership Percentage: 97.71%
Insider Trades by Quarter for Chemed (NYSE:CHE)
Institutional Ownership by Quarter for Chemed (NYSE:CHE)

Chemed (NYSE CHE) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/4/2017Michael D WitzemanVPSell1,000$250.00$250,000.003,334View SEC Filing  
11/29/2017David Patrick WilliamsInsiderSell11,000$241.28$2,654,080.0074,857View SEC Filing  
11/27/2017Naomi C DallobVPSell950$240.38$228,361.009,747View SEC Filing  
11/22/2017Spencer S LeeInsiderSell1,000$238.24$238,240.0034,809View SEC Filing  
11/16/2017Michael D WitzemanVPSell1,579$235.00$371,065.004,334View SEC Filing  
11/15/2017Kevin J McnamaraCEOSell5,000$232.59$1,162,950.00136,800View SEC Filing  
11/15/2017Spencer S LeeInsiderSell1,000$232.27$232,270.0035,809View SEC Filing  
11/13/2017Nicholas Michael WestfallInsiderSell10,000$231.00$2,310,000.0013,351View SEC Filing  
11/8/2017Naomi C DallobVPSell1,900$231.00$438,900.0010,426View SEC Filing  
11/2/2017Donald E SaundersDirectorSell500$227.75$113,875.0010,298View SEC Filing  
11/2/2017Spencer S LeeEVPSell1,000$228.45$228,450.0036,809View SEC Filing  
10/31/2017Kevin J McnamaraCEOSell10,000$223.42$2,234,200.00170,016View SEC Filing  
10/31/2017Naomi C DallobVPSell750$222.09$166,567.509,097View SEC Filing  
10/2/2017Patrick P GraceDirectorSell500$201.48$100,740.004,515View SEC Filing  
9/1/2017Spencer S LeeInsiderSell1,000$197.46$197,460.0037,809View SEC Filing  
7/28/2017Kevin J McnamaraInsiderSell15,000$201.16$3,017,400.00173,801View SEC Filing  
6/26/2017George J Walsh IIIDirectorBuy1,000$204.56$204,560.007,908View SEC Filing  
5/4/2017Donald E SaundersDirectorBuy94$205.59$19,325.469,886View SEC Filing  
5/3/2017Donald E SaundersDirectorSell400$204.85$81,940.009,886View SEC Filing  
5/2/2017Kevin J McnamaraInsiderSell4,000$205.11$820,440.00148,943View SEC Filing  
5/1/2017Spencer S LeeInsiderSell1,000$202.47$202,470.0039,147View SEC Filing  
3/3/2017Kevin J McnamaraInsiderSell7,000$181.74$1,272,180.00149,191View SEC Filing  
3/2/2017Arthur V Tucker JrVPSell2,266$181.00$410,146.001,800View SEC Filing  
2/27/2017Arthur V Tucker JrVPSell8,878$179.21$1,591,026.388,070View SEC Filing  
2/24/2017Kevin J McnamaraInsiderSell7,000$177.63$1,243,410.00160,010View SEC Filing  
11/28/2016Patrick P GraceDirectorSell400$148.53$59,412.004,597View SEC Filing  
11/14/2016Donald E SaundersDirectorSell500$149.56$74,780.0010,286View SEC Filing  
11/14/2016Spencer S LeeInsiderSell4,500$150.22$675,990.0035,367View SEC Filing  
10/31/2016Kevin J McnamaraInsiderSell10,000$138.40$1,384,000.00189,266View SEC Filing  
9/22/2016Spencer S LeeInsiderSell2,000$141.67$283,340.0039,867View SEC Filing  
8/8/2016Donald E SaundersDirectorSell500$144.32$72,160.0010,786View SEC Filing  
8/5/2016Arthur V Tucker JrVPSell4,500$144.28$649,260.007,734View SEC Filing  
8/4/2016Arthur V Tucker JrVPSell3,089$143.88$444,445.323,234View SEC Filing  
8/3/2016Kevin J McnamaraInsiderSell18,000$144.87$2,607,660.00163,266View SEC Filing  
5/16/2016Donald E SaundersDirectorBuy77$126.53$9,742.8111,209View SEC Filing  
3/21/2016Spencer S LeeEVPSell24,382$132.29$3,225,494.7862,087View SEC Filing  
1/27/2016Patrick P GraceDirectorSell50$138.98$6,949.004,522View SEC Filing  
12/11/2015David Patrick WilliamsCFOSell5,000$151.72$758,600.0036,968View SEC Filing  
11/24/2015Spencer S LeeEVPSell5,000$154.10$770,500.0043,405View SEC Filing  
11/6/2015Kevin J McnamaraCEOSell6,000$157.02$942,120.00167,736View SEC Filing  
10/27/2015Spencer S. LeeEVPSell4,000$153.64$614,560.0048,405View SEC Filing  
10/26/2015Kevin J. McnamaraCEOSell8,000$149.04$1,192,320.00173,736View SEC Filing  
8/24/2015David Patrick WilliamsCFOSell10,000$138.09$1,380,900.0029,268View SEC Filing  
5/15/2015Arthur V Tucker JrVPSell9,000$121.00$1,089,000.00View SEC Filing  
5/7/2015Kevin J McnamaraCEOSell8,000$120.82$966,560.00View SEC Filing  
3/6/2015Spencer S LeeEVPSell9,931$115.16$1,143,653.96View SEC Filing  
3/2/2015Timothy S OtooleEVPSell10,000$117.82$1,178,200.00View SEC Filing  
2/27/2015Arthur V Tucker JrVPSell7,000$116.80$817,600.00View SEC Filing  
2/24/2015Arthur V Tucker JrVPSell2,685$114.35$307,029.75View SEC Filing  
2/23/2015Spencer S LeeEVPSell10,000$113.18$1,131,800.00View SEC Filing  
2/20/2015Kevin J McnamaraCEOSell13,000$112.71$1,465,230.00View SEC Filing  
11/14/2014Timothy S OtooleEVPSell5,000$106.81$534,050.00View SEC Filing  
11/13/2014Spencer S LeeEVPSell10,000$108.38$1,083,800.00View SEC Filing  
11/4/2014Kevin J McnamaraCEOSell4,000$104.13$416,520.00View SEC Filing  
9/10/2014Spencer S LeeEVPSell2,000$105.80$211,600.00View SEC Filing  
9/8/2014David Patrick WilliamsCFOSell5,000$105.90$529,500.00View SEC Filing  
8/7/2014Kevin J McnamaraCEOSell5,000$100.05$500,250.00View SEC Filing  
7/25/2014Arthur V Tucker JrVPSell9,000$101.26$911,340.00View SEC Filing  
7/25/2014Kevin J McnamaraCEOSell10,000$101.00$1,010,000.00View SEC Filing  
5/15/2014Timothy OtooleEVPSell9,000$87.62$788,580.0031,170View SEC Filing  
5/5/2014Kevin McnamaraCEOSell5,000$85.05$425,250.00178,710View SEC Filing  
4/2/2014Spencer LeeEVPSell2,000$90.15$180,300.0065,848View SEC Filing  
3/19/2014Thomas HuttonVPSell2,201$88.36$194,480.3628,699View SEC Filing  
3/11/2014Timothy OtooleEVPSell6,000$86.60$519,600.0037,519View SEC Filing  
3/3/2014Kevin McnamaraCEOSell4,000$84.47$337,880.00178,616View SEC Filing  
2/28/2014Arthur Tucker, Jr.VPSell9,000$85.01$765,090.008,282View SEC Filing  
2/25/2014Arthur Tucker, Jr.VPSell8,461$83.80$709,031.808,282View SEC Filing  
2/20/2014Spencer LeeEVPSell2,000$82.51$165,020.0067,848View SEC Filing  
2/19/2014Kevin McnamaraCEOSell4,000$82.18$328,720.00182,616View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Chemed (NYSE CHE) News Headlines

Source:
DateHeadline
Chemed Co. (CHE) Expected to Announce Quarterly Sales of $423.56 MillionChemed Co. (CHE) Expected to Announce Quarterly Sales of $423.56 Million
www.americanbankingnews.com - January 18 at 7:58 AM
Chemed Co. (CHE) Given Consensus Recommendation of "Hold" by BrokeragesChemed Co. (CHE) Given Consensus Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - January 17 at 2:14 AM
Tenet Healthcare (THC) and Chemed (CHE) Head to Head ReviewTenet Healthcare (THC) and Chemed (CHE) Head to Head Review
www.americanbankingnews.com - January 6 at 11:52 AM
$423.56 Million in Sales Expected for Chemed Co. (CHE) This Quarter$423.56 Million in Sales Expected for Chemed Co. (CHE) This Quarter
www.americanbankingnews.com - January 1 at 5:00 AM
Chemed Co. (CHE) Expected to Post Earnings of $2.28 Per ShareChemed Co. (CHE) Expected to Post Earnings of $2.28 Per Share
www.americanbankingnews.com - December 30 at 5:10 PM
Haemonetics Banks on Hospital Business, Competition RifeHaemonetics Banks on Hospital Business, Competition Rife
finance.yahoo.com - December 26 at 9:33 AM
Chemed Co. (CHE) Given Average Recommendation of "Hold" by BrokeragesChemed Co. (CHE) Given Average Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - December 23 at 1:52 AM
Zacks.com highlights: Lululemon Athletica, Chemed, Baxter International, NVR and CopartZacks.com highlights: Lululemon Athletica, Chemed, Baxter International, NVR and Copart
finance.yahoo.com - December 21 at 9:19 AM
Chemed (CHE) and Acadia Healthcare (ACHC) Head to Head SurveyChemed (CHE) and Acadia Healthcare (ACHC) Head to Head Survey
www.americanbankingnews.com - December 21 at 1:16 AM
5 of the Best Efficient Stocks to Strengthen Your Portfolio5 of the Best Efficient Stocks to Strengthen Your Portfolio
finance.yahoo.com - December 20 at 10:04 AM
Cincinnati, Explained: Our answers to your questionsCincinnati, Explained: Our answers to your questions
www.bizjournals.com - December 15 at 9:37 AM
Chemed Co. (CHE) Expected to Post Quarterly Sales of $423.56 MillionChemed Co. (CHE) Expected to Post Quarterly Sales of $423.56 Million
www.americanbankingnews.com - December 15 at 6:24 AM
Critical Analysis: Streamline Health Solutions (STRM) versus Chemed (CHE)Critical Analysis: Streamline Health Solutions (STRM) versus Chemed (CHE)
www.americanbankingnews.com - December 14 at 7:52 PM
ETFs with exposure to Chemed Corp. : December 13, 2017ETFs with exposure to Chemed Corp. : December 13, 2017
finance.yahoo.com - December 13 at 5:02 PM
Zacks: Brokerages Anticipate Chemed Co. (CHE) to Announce $2.28 Earnings Per ShareZacks: Brokerages Anticipate Chemed Co. (CHE) to Announce $2.28 Earnings Per Share
www.americanbankingnews.com - December 13 at 3:53 PM
DaVita (DVA) Surges: Stock Moves 13.6% HigherDaVita (DVA) Surges: Stock Moves 13.6% Higher
www.zacks.com - December 7 at 9:24 AM
Chemed Banks on Roto-Rooter Sales, Focuses on Vitas RevivalChemed Banks on Roto-Rooter Sales, Focuses on Vitas Revival
finance.yahoo.com - December 7 at 9:24 AM
Align Technology Rides High on InvisAlign & Strategic PactsAlign Technology Rides High on InvisAlign & Strategic Pacts
finance.yahoo.com - December 6 at 9:29 AM
Chemed Corp. (CHE) VP Michael D. Witzeman Sells 1,000 SharesChemed Corp. (CHE) VP Michael D. Witzeman Sells 1,000 Shares
www.americanbankingnews.com - December 4 at 11:42 AM
Zacks.com highlights: Chemed, Baxter International, IDEXX Laboratories, Advanced Energy Industries and Pioneer Natural ResourcesZacks.com highlights: Chemed, Baxter International, IDEXX Laboratories, Advanced Energy Industries and Pioneer Natural Resources
finance.yahoo.com - December 4 at 9:15 AM
Chemed (CHE) Rating Lowered to Hold at ValuEngineChemed (CHE) Rating Lowered to Hold at ValuEngine
www.americanbankingnews.com - December 3 at 7:58 PM
Financial Contrast: Chemed (CHE) and Laboratory Corporation of America (LH)Financial Contrast: Chemed (CHE) and Laboratory Corporation of America (LH)
www.americanbankingnews.com - December 3 at 1:24 AM
Heres Why You Should Add Chemed (CHE) to Your Portfolio NowHere's Why You Should Add Chemed (CHE) to Your Portfolio Now
finance.yahoo.com - December 1 at 4:42 PM
Here's Why You Should Add Chemed (CHE) to Your Portfolio NowHere's Why You Should Add Chemed (CHE) to Your Portfolio Now
finance.yahoo.com - December 1 at 4:42 PM
Insider Selling: Chemed Corp. (CHE) Insider Sells 11,000 Shares of StockInsider Selling: Chemed Corp. (CHE) Insider Sells 11,000 Shares of Stock
www.americanbankingnews.com - November 30 at 10:30 AM
Chemed (CHE) Up 13.6% Since Earnings Report: Can It Continue?Chemed (CHE) Up 13.6% Since Earnings Report: Can It Continue?
finance.yahoo.com - November 28 at 4:49 PM
Chemed Corp. (CHE) Receives Consensus Recommendation of "Hold" from AnalystsChemed Corp. (CHE) Receives Consensus Recommendation of "Hold" from Analysts
www.americanbankingnews.com - November 28 at 1:36 AM
Chemed Corp. (CHE) VP Naomi C. Dallob Sells 950 SharesChemed Corp. (CHE) VP Naomi C. Dallob Sells 950 Shares
www.americanbankingnews.com - November 27 at 1:36 PM
$423.56 Million in Sales Expected for Chemed Corp. (CHE) This Quarter$423.56 Million in Sales Expected for Chemed Corp. (CHE) This Quarter
www.americanbankingnews.com - November 27 at 4:36 AM
 Brokerages Anticipate Chemed Corp. (CHE) Will Post Earnings of $2.28 Per Share Brokerages Anticipate Chemed Corp. (CHE) Will Post Earnings of $2.28 Per Share
www.americanbankingnews.com - November 25 at 7:12 PM
Chemed Corp. (CHE) Insider Sells $238,240.00 in StockChemed Corp. (CHE) Insider Sells $238,240.00 in Stock
www.americanbankingnews.com - November 22 at 2:02 PM
Insider Selling: Chemed Corp. (CHE) VP Sells 1,579 Shares of StockInsider Selling: Chemed Corp. (CHE) VP Sells 1,579 Shares of Stock
www.americanbankingnews.com - November 17 at 1:48 PM
Chemed Corp. (CHE) Insider Sells $232,270.00 in StockChemed Corp. (CHE) Insider Sells $232,270.00 in Stock
www.americanbankingnews.com - November 16 at 4:48 PM
Kevin J. Mcnamara Sells 5,000 Shares of Chemed Corp. (CHE) StockKevin J. Mcnamara Sells 5,000 Shares of Chemed Corp. (CHE) Stock
www.americanbankingnews.com - November 16 at 4:22 PM
ETFs with exposure to Chemed Corp. : November 14, 2017ETFs with exposure to Chemed Corp. : November 14, 2017
finance.yahoo.com - November 14 at 5:41 PM
Chemed Corp. (CHE) Insider Sells $2,310,000.00 in StockChemed Corp. (CHE) Insider Sells $2,310,000.00 in Stock
www.americanbankingnews.com - November 14 at 1:32 PM
Head to Head Comparison: Chemed Corp. (CHE) and The Joint Corp. (JYNT)Head to Head Comparison: Chemed Corp. (CHE) and The Joint Corp. (JYNT)
www.americanbankingnews.com - November 9 at 10:26 AM
Chemed Corp. (CHE) VP Naomi C. Dallob Sells 1,900 SharesChemed Corp. (CHE) VP Naomi C. Dallob Sells 1,900 Shares
www.americanbankingnews.com - November 8 at 12:40 PM
Zacks: Analysts Expect Chemed Corp. (CHE) Will Post Quarterly Sales of $423.56 MillionZacks: Analysts Expect Chemed Corp. (CHE) Will Post Quarterly Sales of $423.56 Million
www.americanbankingnews.com - November 8 at 2:06 AM
 Analysts Expect Chemed Corp. (CHE) Will Post Earnings of $2.28 Per Share Analysts Expect Chemed Corp. (CHE) Will Post Earnings of $2.28 Per Share
www.americanbankingnews.com - November 6 at 11:26 PM
Insider Selling: Chemed Corp. (CHE) Director Sells 500 Shares of StockInsider Selling: Chemed Corp. (CHE) Director Sells 500 Shares of Stock
www.americanbankingnews.com - November 6 at 3:34 PM
Chemed Corp. to Issue Dividend of $0.28 (CHE)Chemed Corp. to Issue Dividend of $0.28 (CHE)
www.americanbankingnews.com - November 4 at 10:56 AM
Chemed Corporation Declares Quarterly Dividend of 28 CentsChemed Corporation Declares Quarterly Dividend of 28 Cents
finance.yahoo.com - November 4 at 7:40 AM
Insider Selling: Chemed Corp. (CHE) EVP Sells 1,000 Shares of StockInsider Selling: Chemed Corp. (CHE) EVP Sells 1,000 Shares of Stock
www.americanbankingnews.com - November 3 at 2:44 PM
Chemed Corp. (CHE) Given Consensus Recommendation of "Hold" by BrokeragesChemed Corp. (CHE) Given Consensus Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - November 3 at 5:46 AM
ETFs with exposure to Chemed Corp. : November 2, 2017ETFs with exposure to Chemed Corp. : November 2, 2017
finance.yahoo.com - November 2 at 6:00 PM
Zacks Investment Research Upgrades Chemed Corp. (CHE) to "Buy"Zacks Investment Research Upgrades Chemed Corp. (CHE) to "Buy"
www.americanbankingnews.com - November 2 at 2:20 PM
KeyCorp Weighs in on Chemed Corp.s FY2017 Earnings (CHE)KeyCorp Weighs in on Chemed Corp.'s FY2017 Earnings (CHE)
www.americanbankingnews.com - November 2 at 9:28 AM
Chemed Corp. :CHE-US: Earnings Analysis: Q3, 2017 By the Numbers : November 1, 2017Chemed Corp. :CHE-US: Earnings Analysis: Q3, 2017 By the Numbers : November 1, 2017
finance.yahoo.com - November 1 at 5:54 PM
Chemed Corp. (CHE) VP Sells $166,567.50 in StockChemed Corp. (CHE) VP Sells $166,567.50 in Stock
www.americanbankingnews.com - November 1 at 2:44 PM

SEC Filings

Chemed (NYSE:CHE) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Chemed (NYSE:CHE) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Chemed (NYSE CHE) Stock Chart for Thursday, January, 18, 2018

Loading chart…

This page was last updated on 1/18/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.